Correlation Between Precision BioSciences and Zymeworks Common
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Zymeworks Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Zymeworks Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Zymeworks Common Stock, you can compare the effects of market volatilities on Precision BioSciences and Zymeworks Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Zymeworks Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Zymeworks Common.
Diversification Opportunities for Precision BioSciences and Zymeworks Common
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Precision and Zymeworks is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Zymeworks Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zymeworks Common Stock and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Zymeworks Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zymeworks Common Stock has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Zymeworks Common go up and down completely randomly.
Pair Corralation between Precision BioSciences and Zymeworks Common
Given the investment horizon of 90 days Precision BioSciences is expected to generate 1.94 times more return on investment than Zymeworks Common. However, Precision BioSciences is 1.94 times more volatile than Zymeworks Common Stock. It trades about 0.05 of its potential returns per unit of risk. Zymeworks Common Stock is currently generating about -0.06 per unit of risk. If you would invest 426.00 in Precision BioSciences on December 28, 2024 and sell it today you would earn a total of 28.00 from holding Precision BioSciences or generate 6.57% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Precision BioSciences vs. Zymeworks Common Stock
Performance |
Timeline |
Precision BioSciences |
Zymeworks Common Stock |
Precision BioSciences and Zymeworks Common Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Precision BioSciences and Zymeworks Common
The main advantage of trading using opposite Precision BioSciences and Zymeworks Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Zymeworks Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zymeworks Common will offset losses from the drop in Zymeworks Common's long position.Precision BioSciences vs. X4 Pharmaceuticals | Precision BioSciences vs. Acumen Pharmaceuticals | Precision BioSciences vs. Inozyme Pharma | Precision BioSciences vs. Terns Pharmaceuticals |
Zymeworks Common vs. Day One Biopharmaceuticals | Zymeworks Common vs. Inozyme Pharma | Zymeworks Common vs. Zentalis Pharmaceuticals Llc | Zymeworks Common vs. Syndax Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |